论文信息 - First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors - 字舞流文

First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors

M. Shah | P. Maliakal | D. Goldenberg | V. Picozzi | R. Sharkey | S. Govindan | L. Vahdat | W. Wegener | A. Starodub | A. Ocean | M. Guarino | Sajev Thomas | S. Hamburger